Toll-like receptors as targets for immune disorders
Authors:
- Brian KeoghBKBrian Keogh
- Andrew E. ParkerAPAndrew E. Parker
- 1 July 2011
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 32 (7) , 435-442
Abstract
No abstract availableKeywords
This publication has 106 references indexed in Scilit:
- Application of a novel in silico high-throughput screen to identify selective inhibitors for protein–protein interactionsBioorganic & Medicinal Chemistry Letters, 2010
- Discovery of a novel TLR2 signaling inhibitor with anti-viral activityAntiviral Research, 2010
- Evidence that tricyclic small molecules may possess toll-like receptor and myeloid differentiation protein 2 activityNeuroscience, 2010
- The role of pattern-recognition receptors in innate immunity: update on Toll-like receptorsNature Immunology, 2010
- Evidence that intrathecal morphine-3-glucuronide may cause pain enhancement via toll-like receptor 4/MD-2 and interleukin-1βNeuroscience, 2010
- Allergenicity resulting from functional mimicry of a Toll-like receptor complex proteinNature, 2008
- The dynamics of effector T cells and Foxp3+ regulatory T cells in the promotion and regulation of autoimmune encephalomyelitisJournal of Neuroimmunology, 2007
- Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophagesNature, 2006
- The glial modulatory drug AV411 attenuates mechanical allodynia in rat models of neuropathic painNeuron Glia Biology, 2006
- Inflammation in atherosclerosisNature, 2002